• Featured Product
  • KD/KO Validated

TUSC3 Polyclonal antibody

TUSC3 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

Cat no : 16039-1-AP

Synonyms

M33, MRT7, N33, OST3A, Protein N33, tumor suppressor candidate 3, TUSC3



Tested Applications

Positive WB detected inHeLa cells, rat testis tissue, mouse brain tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:3000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

16039-1-AP targets TUSC3 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen TUSC3 fusion protein Ag8912
Full Name tumor suppressor candidate 3
Calculated Molecular Weight 347 aa, 40 kDa
Observed Molecular Weight 35-40 kDa
GenBank Accession NumberBC010370
Gene Symbol TUSC3
Gene ID (NCBI) 7991
RRIDAB_2878208
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

TUSC3 (tumor suppressor candidate 3), originally named N33, is a potential tumor supressor gene. Decreased expression of TUSC3 has been found in various cancers, including prostate cancer, pancreas cancer and ovary cancer. TUSC3 also known as OST3A, is identified as a part of the oligosaccharyl-transferase (OST) complex and plays a crucial role in protein N-glycosylation. TUSC3 mutations have been found in families with non-syndromic autosomal recessive mental retardation.

Protocols

Product Specific Protocols
WB protocol for TUSC3 antibody 16039-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle

Nat Commun

miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC.

Authors - Young-Jun Jeon
humanWB

J Cell Biol

Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins.

Authors - Natalia A Cherepanova
  • KD Validated
humanWB

Sci Rep

Mammalian cells lacking either the cotranslational or posttranslocational oligosaccharyltransferase complex display substrate-dependent defects in asparagine linked glycosylation.

Authors - Natalia A Cherepanova
  • KD Validated
humanWB

J Biol Chem

ER entry pathway and glycosylation of GPI-anchored proteins are determined by N-terminal signal sequence and C-terminal GPI-attachment sequence

Authors - Tetsuya Hirata
humanIHC

J Transl Med

Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis

Authors - Ruxia Deng
  • KD Validated
humanWB

J Allergy Clin Immunol

Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease

Authors - Haodong Ding